Ana Valeria Meléndez

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 6

Top Topics

Helicobacter Pylori Infection

Top Venues

Journal of translational medicine

Cellular and molecular life sciences : CMLS

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)
Ana Valeria Meléndez, Rubí M-H Velasco Cárdenas, Simon Lagies, Juliane Strietz, Lina Siukstaite, Oliver S Thomas, Jana Tomisch, Wilfried Weber, Bernd Kammerer, Winfried Römer, Susana Minguet
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells. Cellular and molecular life sciences : CMLS 79 (10) (2022)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)